Literature DB >> 2205510

Expression of HLA by the human trabecular meshwork and corneal endothelium.

B J Tripathi1, R C Tripathi, P Wong, S Raja.   

Abstract

By using immunohistochemical techniques, we demonstrated that HLA class I (A, B and C) and HLA class II (DR), the major histocompatibility antigens in man, are expressed constitutively by cells of the trabecular meshwork/Schlemm's canal system and corneal endothelium, as well as by the conjunctival epithelium, Langerhans cells, vascular endothelium and uvea. Because clinical studies indicate that these antigens are involved in mediating corneal graft rejection and possibly in glaucomatous disease of the eye, the presence of both class I and II HLA in the corneal endothelium and in the trabecular cells has important implications for an understanding of immune disorders in the anterior segment of the eye. The presence of HLA on trabecular cells raises the possibility that these antigens potentiate the recognized role of Langerhans cells at the limbus and that they participate in, and/or regulate, the maintenance and defense of the aqueous outflow pathway. Our findings also open up the possibility of using HLA as a genetic marker in the determination of susceptibility to these disorders in man.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2205510     DOI: 10.1016/0014-4835(90)90023-n

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  9 in total

1.  Human trabecular meshwork cells exhibit several characteristics of, but are distinct from, adipose-derived mesenchymal stem cells.

Authors:  Joshua T Morgan; Joshua A Wood; Naomi J Walker; Vijay Krishna Raghunathan; Dori L Borjesson; Christopher J Murphy; Paul Russell
Journal:  J Ocul Pharmacol Ther       Date:  2014-01-23       Impact factor: 2.671

2.  The influence of penetrating keratoplasty and cyclosporin A therapy on MHC class II (Ia)-positive cells in the rat iris and choroid.

Authors:  S E Coupland; L Krause; F Hoffmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-02       Impact factor: 3.117

3.  Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultrastructural study.

Authors:  R Nuzzi; A Vercelli; C Finazzo; C Cracco
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-03       Impact factor: 3.117

4.  Orthotopic corneal transplantation in the mouse--a new surgical technique with minimal endothelial cell loss.

Authors:  E P Zhang; S Schründer; F Hoffmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-11       Impact factor: 3.117

Review 5.  The many faces of the trabecular meshwork cell.

Authors:  W Daniel Stamer; Abbot F Clark
Journal:  Exp Eye Res       Date:  2016-07-19       Impact factor: 3.467

6.  Clinical and immunohistochemical correlation of herpetic keratitis with the expression of HLA-DR antigen.

Authors:  S Tang; O F Scheiffarth; F H Stefani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-03       Impact factor: 3.117

7.  Feasibility study of lamellar keratoplasty in a murine model.

Authors:  Ting Huang; Stephen R Planck; James T Rosenbaum; Ellen J Lee
Journal:  Ocul Immunol Inflamm       Date:  2009 Jul-Aug       Impact factor: 3.070

8.  Serial analysis of gene expression (SAGE) in normal human trabecular meshwork.

Authors:  Yutao Liu; Drew Munro; David Layfield; Andrew Dellinger; Jeffrey Walter; Katherine Peterson; Catherine Bowes Rickman; R Rand Allingham; Michael A Hauser
Journal:  Mol Vis       Date:  2011-04-08       Impact factor: 2.367

9.  Emergent Temporal Signaling in Human Trabecular Meshwork Cells: Role of TRPV4-TRPM4 Interactions.

Authors:  Oleg Yarishkin; Tam T T Phuong; Felix Vazquez-Chona; Jacques Bertrand; Joseph van Battenburg-Sherwood; Sarah N Redmon; Christopher N Rudzitis; Monika Lakk; Jackson M Baumann; Marc Freichel; Eun-Mi Hwang; Darryl Overby; David Križaj
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.